| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/10/2011 | CN1895672B Multifunctional broad-spectrum obtundent of polyphyletic synergistic and its use |
| 08/10/2011 | CN1895324B Jinganmin dispersing tablets and preparation thereof |
| 08/10/2011 | CN1882591B 5,7-diaminopyrazolo '4,3-d!pyrimidines with pde-5 inhibiting activity |
| 08/10/2011 | CN1861131B Qingkailing dixinwan pill prepn. and its prepn. method |
| 08/10/2011 | CN1853627B Cyclodextrin of bibenziisosehenazole ethane or cyclodextrin derivative inclusion compound, and preparation and use thereof |
| 08/10/2011 | CN1562044B Witamin D2 calcium levulinate freeze-dried emulsion and its preparing method |
| 08/10/2011 | CN1551878B 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 08/10/2011 | CN1129942B Aza spiro-compounds acting on the cholinergic system with muscarinic agonist activity |
| 08/10/2011 | CN102149723A Novel glucopyranose derivatives, preparation thereof, and biological uses thereof |
| 08/10/2011 | CN102149721A Aminophosphinic derivatives that can be used in the treatment of pain |
| 08/10/2011 | CN102149717A Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives |
| 08/10/2011 | CN102149714A Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 08/10/2011 | CN102149713A Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof |
| 08/10/2011 | CN102149712A Pyrazole [3, 4-b] pyridine Raf inhibitors |
| 08/10/2011 | CN102149711A Organic compounds |
| 08/10/2011 | CN102149710A Cyclopentathiophene modulators of the glucocorticoid receptor, AP-1, and/or NF-Kappa B activity and use thereof |
| 08/10/2011 | CN102149709A Novel crystal forms of 4-(2-aminopyridin-4-yl)-3-(4-fluorophenyl)-1-(1,4,5,6-tetrahydro-6-oxopyridazin-3-yl)-1H-pyrazole methanesulfonate and methods for their preparation |
| 08/10/2011 | CN102149708A Pyrrolidin-2-ones as HDM2 ligands |
| 08/10/2011 | CN102149706A Antineoplastic derivatives of 4-oxo-L,4-dihydro-quinoline, preparation thereof, and therapeutic use thereof |
| 08/10/2011 | CN102149705A [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1H-indol-3-yl]-methanone as an inhibitor of mast cell tryptase |
| 08/10/2011 | CN102149703A Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers |
| 08/10/2011 | CN102149702A Novel methylenedioxy phenolic compounds and their use to treat disease |
| 08/10/2011 | CN102149700A Novel salts and polymorphs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 08/10/2011 | CN102149698A 5-substituted benzoxazines |
| 08/10/2011 | CN102149697A 6-substituted benzoxazines as 5-HT-5A receptor antagonists |
| 08/10/2011 | CN102149693A Triazole compounds, use thereof, and agents containing same |
| 08/10/2011 | CN102149691A Triazole compounds, the use thereof and preparations containing these compounds |
| 08/10/2011 | CN102149690A Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivative containing phenyl group having sulfonic acid ester structure introduced therein as substituent |
| 08/10/2011 | CN102149689A Substituted 1-benzyl-cinnolin-4(1H)-one derivatives, preparation thereof, and therapeutic use thereof |
| 08/10/2011 | CN102149688A New benzimidazole derivatives |
| 08/10/2011 | CN102149687A Novel imidazolidine compounds as androgen receptor modulators |
| 08/10/2011 | CN102149685A Isoquinolinone derivatives as NK3 antagonists |
| 08/10/2011 | CN102149681A Piperazine derivatives for binding and imaging amyloid plaques and their use |
| 08/10/2011 | CN102149680A Nitrogen-containing aromatic heterocyclyl compound |
| 08/10/2011 | CN102149678A Novel ortho-aminoanilides for the treatment of cancer |
| 08/10/2011 | CN102149677A Bi-aryl aminotetralines |
| 08/10/2011 | CN102149676A Monoaryl aminotetralines |
| 08/10/2011 | CN102149673A Fatty acid acetylated salicylates and their uses |
| 08/10/2011 | CN102149671A Polymorphic form of rasagiline mesylate |
| 08/10/2011 | CN102149432A Organoarsenic compounds and methods for the treatment of cancer |
| 08/10/2011 | CN102149410A Composite organic compound powder for medical use, method for producing same and suspension of same |
| 08/10/2011 | CN102149408A Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
| 08/10/2011 | CN102149400A Compositions that aim to promote the development and growth of a beneficial vaginal microflora |
| 08/10/2011 | CN102149399A Method for producing a composition with a high content of sapogenin |
| 08/10/2011 | CN102149393A Antimicrobial silver solutions |
| 08/10/2011 | CN102149392A Gentle, non-irritating, non-alcohoholic skin disinfectant |
| 08/10/2011 | CN102149391A Compositions and methods for treatment of neoplastic disease |
| 08/10/2011 | CN102149390A Complement antagonists and uses thereof |
| 08/10/2011 | CN102149389A Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
| 08/10/2011 | CN102149388A Novel acetates of 2-deoxy monosaccharides with anticancer activity |
| 08/10/2011 | CN102149387A Pharmaceutical composition comprising risedronic acid or a salt thereof and vitamin D |
| 08/10/2011 | CN102149386A Novel pharmaceutical composition for treating nociceptive pain |
| 08/10/2011 | CN102149385A Chemical compounds |
| 08/10/2011 | CN102149384A Heterocyclic amide derivatives as EP4 receptor antagonists |
| 08/10/2011 | CN102149383A Pharmaceutical agent, food or beverage having inhibitory activity on serotonin transporter |
| 08/10/2011 | CN102149382A New therapeutic use of drotaverine |
| 08/10/2011 | CN102149381A A pharmaceutical composition for preventing or treating osteoporosis comprising benzamidine derivative or its salt, and bisphosphonate |
| 08/10/2011 | CN102149380A A pharmaceutical composition for preventing or treating osteoporosis comprising benzamidine derivatives or their salts, and alendronic acid or its salt |
| 08/10/2011 | CN102149379A Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 08/10/2011 | CN102149378A Indication of use of erdosteine as antidote in a large number of intoxications, especially in heavy metals like lead or mercury, and paracetamol |
| 08/10/2011 | CN102149377A Use of dronedarone for the preparation of a medicament for the prevention of stroke or transient ischemic attack |
| 08/10/2011 | CN102149376A Long-term treatment of symptomatic heart failure |
| 08/10/2011 | CN102149375A Human Beta3 adrenergic receptor ligand, and food or pharmaceutical product containing the same |
| 08/10/2011 | CN102149374A Orally administrable formulation containing branched chain amino acid |
| 08/10/2011 | CN102149373A 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases |
| 08/10/2011 | CN102149367A Improvements relating to nanodisperse compositions |
| 08/10/2011 | CN102149281A Method for controlling plant disease |
| 08/10/2011 | CN102147360A Detection method for drug combination |
| 08/10/2011 | CN102146115A 3-substituent-B-Homo-steride-B-cyclolactam compound as well as preparation method and application to preparing antitumor medicaments |
| 08/10/2011 | CN102146111A New dinucleotide compound and preparation method thereof |
| 08/10/2011 | CN102146108A Synthesis of 3'-triazoepirubicin with anticancer activity |
| 08/10/2011 | CN102146107A Synthesis and anti-tumor activity of (S)-2-hydroxyalkyl-1,4-dihydroxyl-9-10-anthraquinone and glycosyl conjugates |
| 08/10/2011 | CN102146096A Aniline quinazoline compound as well as preparation method and application thereof |
| 08/10/2011 | CN102146095A Pyrrole indolone compounds and preparation method and use thereof |
| 08/10/2011 | CN102146088A Copper complex of phenanthroline derivatives and preparation method and application thereof |
| 08/10/2011 | CN102146085A 9-oxime-ether ketolide derivative, and preparation method and medical composite thereof |
| 08/10/2011 | CN102146084A 3-cyan-6-aminoquinoline derivatives, preparation method thereof and application thereof in medicines |
| 08/10/2011 | CN102146082A Medicinal salts of pyrrolo-nitrogenous heterocyclic derivatives, and preparation method and application thereof to medicines |
| 08/10/2011 | CN102146081A Indoleacetic acid derivatives and preparation method and application thereof |
| 08/10/2011 | CN102146080A Beta-carboline alkali derivative compounds and application thereof |
| 08/10/2011 | CN102146078A Substituted propanamide compounds and preparation method and application thereof |
| 08/10/2011 | CN102146076A Novel anilinoquinazoline derivatives and preparation method thereof |
| 08/10/2011 | CN102146074A Preparation method of pyrrole derivative and application thereof |
| 08/10/2011 | CN102146066A C-glucoside derivatives containing saturated six-membered ring as well as preparation method and application thereof |
| 08/10/2011 | CN102146062A Thiazolidine neuraminidase inhibitor and application thereof |
| 08/10/2011 | CN102146059A Quinazoline derivatives and preparation method and application thereof |
| 08/10/2011 | CN102146057A C19-diterpenoid alkaloid, preparation method of C19-diterpenoid alkaloid, medical composite with C19-diterpenoid alkaloid used as active ingredient and application of medical composite |
| 08/10/2011 | CN102146056A N-benzyl-acridone, derivatives of N-benzyl-acridone and preparation methods and application of N-benzyl-acridone and derivatives |
| 08/10/2011 | CN102146054A Piperlongumine derivatives and medicinal composition and application to preparation of medicament for inhibiting tumor growth thereof |
| 08/10/2011 | CN102146053A 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disorders |
| 08/10/2011 | CN102146040A 2-(4-Chlorophenoxy)-2-methylpropionic acid methoxyphenyl propionate compound and synthesis method thereof |
| 08/10/2011 | CN102146026A Protosappanin A derivative and preparation method and application thereof |
| 08/10/2011 | CN102146014A Method for extracting squalene by using camellia oleosa seeds as raw materials and tea oil and squalene soft capsules |
| 08/10/2011 | CN102145181A siRNA for inhibiting tumor growth and oligomeric nucleic acid combination and application of siRNA |
| 08/10/2011 | CN102145180A Application of miR-34c in preparation of medicaments or health-care products for treating or preventing liver cancers |
| 08/10/2011 | CN102145175A Sorafenib tosylate-hydroxypropyl-beta-cyclodextrin clathrate compound and preparation method thereof |
| 08/10/2011 | CN102145172A Composition for improving absorbance of aminoglycoside drug |
| 08/10/2011 | CN102145170A Sensitizer for radiotherapy and chemotherapy of malignant tumor |
| 08/10/2011 | CN102145159A Ginger and elecampane composition, preparation method of ginger and elecampane composition and use of ginger and elecampane composition for preparing toxicity-reducing efficacy-improving medicine in cancer radiotherapy and chemotherapy |
| 08/10/2011 | CN102145158A Ginger and clove composition, preparation method of ginger and clove composition and use of ginger and clove composition for preparing toxicity-reducing efficacy-improving medicine in cancer radiotherapy and chemotherapy |